XENE
Xenon Pharmaceuticals Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website xenon-pharma.com
- Employees(FY) 203
- ISIN CA98420N1050
Performance
+5.61%
1W
+1.61%
1M
-8.91%
3M
+35.04%
6M
-6.8%
YTD
+1.01%
1Y
Profile
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, a Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epileptic encephalopathy; and XEN1101, a Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other indications, including adult focal epilepsy. It has a license and collaboration agreement with the Neurocrine Biosciences, Inc. to develop treatments for epilepsy. The company was incorporated in 1996 and is headquartered in Burnaby, Canada.
Investment Analysis Report: XENE
Overview
XENE is a pharmaceutical company operating in the Health Technology sector, specifically in the Pharmaceuticals: Major industry. The company has a market capitalization of $3.61 billion. In this report, we will conduct a comprehensive analysis of XENE's financial statements to evaluate its valuation, fin...
Technical Analysis of XENE 2024-05-03
Overview:
In analyzing the technical indicators for XENE over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average (MA) has been trending above the Simpl...
Recent News & Updates
- 2024-05-08 16:01
- 2024-05-08 04:01
- 2024-05-07 16:01
- 2024-05-07 04:01
- 2024-05-06 12:00
- 2024-05-06 00:00
- 2024-05-02 16:01
- 2024-05-02 04:01
- 2024-04-16 08:30
- 2024-04-15 20:30
- 2024-04-10 08:30
- 2024-04-09 20:30
- 2024-04-04 16:01
- 2024-04-04 04:01
- 2024-03-19 06:16
- 2024-03-12 16:01
- 2024-03-12 04:01
- 2024-03-08 23:55
- 2024-03-05 16:01
- 2024-03-05 03:01
- 2024-03-02 08:37
- 2024-03-01 08:35
- 2024-02-29 19:35
- 2024-02-29 16:34
- 2024-02-29 16:13
Xenon Pharmaceuticals: Q4 Earnings Snapshot(Associated Press Finance)
- 2024-02-29 16:01
- 2024-02-29 03:01
- 2024-02-22 16:01
- 2024-02-22 03:01
- 2024-02-21 22:08
Page 1 of 5
previousnext